Wolverine Trading
PROF

Wolverine Trading’s Profound Medical PROF Stock Holding History

Wolverine Trading’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,811
Closed -$104K – 6228
2021
Q4 		$128K Buy
+10,811
New +$135K ﹤0.01% 4971

Other funds holding PROF

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Wolverine Trading's PROF Position: Q1 2022 in Review

Wolverine Trading sold out of Profound Medical (PROF) in Q1 2022, closing a stake of 10,811 shares — an estimated $104K sold.

Wolverine Trading first reported a position in PROF in Q4 2021 and held it in 1 quarter. The position peaked at $128K in Q4 2021. 44 funds tracked by Wall St. Rank hold PROF as of Q1 2022.

  • Wolverine Trading reported no remaining Profound Medical position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 10,811 Profound Medical shares in Q1 2022, an estimated $104K.
  • Wolverine Trading first reported a position in Profound Medical in Q4 2021 and held it in 1 quarter.
  • Wolverine Trading's Profound Medical position peaked at $128K in Q4 2021.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.